Carnosine research, organized.
More than three thousand peer-reviewed studies reference carnosine. We have indexed the most influential — clinical trials, animal work, in vitro mechanism studies, and modern reviews — and grouped them into eight categories. Pick a category to dive in, or search the entire archive.
From research to clinic.
Every entry below links back to its primary source, so you can trace a claim from headline to methods in a single step.
A century of inquiry.
Carnosine has moved from biochemical curiosity to translational target. Selected milestones below.
- 1900
Russian chemist Vladimir Gulewitsch isolates carnosine from beef extract.
- 1953
Severin describes the pH-buffering role of carnosine in skeletal muscle.
- 1992
Boldyrev establishes carnosine's antioxidant action in neural tissue.
- 2010s
β-alanine supplementation validated as a reliable means of elevating muscle carnosine.
- 2020s
Translational programs target healthy aging, AGE accumulation, and neurodegeneration.
One molecule, six chemistries.
pH Buffering
Imidazole-ring proton acceptance neutralizes H⁺ generated by anaerobic glycolysis, extending muscular work capacity.
Antioxidant Defense
Direct quenching of singlet oxygen, hydroxyl radicals, and reactive carbonyl species.
Anti-Glycation
Outcompetes proteins for reactive aldehydes, reducing AGE formation that stiffens tissues with age.
Metal Chelation
Binds Cu²⁺ and Zn²⁺ to prevent Fenton chemistry and modulate neural metal homeostasis.
Neuroprotection
Reduces β-amyloid aggregation and protects synaptic membranes from peroxidation.
Metabolic Modulation
Improves mitochondrial efficiency and supports insulin sensitivity in preclinical models.
Eight categories. One molecule.
All studies
Brain type carnosinase in dementia: a pilot study
An exploratory clinical study comparing brain-type carnosinase activity in patients with dementia against age-matched controls. The investigators report reduced enzymatic activity in the dementia cohort, raising the possibility that disrupted carnosine turnover is part of the upstream biology of cognitive decline rather than a downstream consequence.
Carnosine supplementation in elderly subjects: a randomized, double-blind, placebo-controlled trial
Double-blind randomized trial in healthy older adults receiving oral carnosine versus placebo over a defined treatment window. Active supplementation was associated with measurable gains across cognitive testing batteries and functional performance, supporting carnosine's role as a broad-spectrum geroprotective intervention.
L-homocarnosine, L-carnosine, and anserine attenuate brain oxidative damage in a pentylenetetrazole-induced epilepsy model of ovariectomized rats
Ovariectomized rats — a model of estrogen-deficient oxidative vulnerability — were exposed to a chemoconvulsant challenge with and without histidine-dipeptide pretreatment. Carnosine and its analogues blunted markers of seizure-driven oxidative damage in brain tissue, pointing to a shared neuroprotective mechanism across the imidazole dipeptide family.
Carnosine is neuroprotective against permanent focal cerebral ischemia in mice
A murine model of permanent focal cerebral ischemia compared infarct volume and neurological scoring between carnosine-treated animals and controls. The treated group showed smaller lesion volumes and better functional outcomes, building the preclinical case for carnosine as an adjunct in acute ischemic brain injury.
β-alanyl-L-histidine rescues cognitive deficits caused by feeding a high fat diet in a transgenic mouse model of Alzheimer's disease
Transgenic Alzheimer's-model mice on a high-fat diet — a setup that accelerates cognitive decline — were supplemented with carnosine. The intervention preserved performance on memory tasks, suggesting carnosine offsets some of the metabolic and oxidative drivers that link diet to neurodegeneration.
Carnosine and its possible roles in nutrition and health
A comprehensive overview of carnosine's dietary sources, absorption profile, and physiological roles. The author synthesizes evidence for buffering, antioxidant action, glycation control, and neuroprotection, and weighs the nutritional implications for omnivorous versus plant-only diets.
Pivotal role of carnosine in the modulation of brain cells activity: multimodal mechanism of action and therapeutic potential in neurodegenerative disorders
A modern mechanistic review arguing that carnosine influences brain cell biology through several converging pathways — redox balance, metal handling, anti-inflammatory signaling, and energy metabolism — rather than a single dominant mechanism. The authors map these pathways onto Alzheimer's and Parkinson's pathophysiology.
Carnosine in health and disease
A wide-angle review that walks through carnosine's chemistry, distribution, and physiological roles before surveying the clinical evidence in neurodegeneration, metabolic disease, and oncology. Particularly useful for grounding why one dipeptide shows up so often across unrelated disease literatures.
Carnosine and the processes of ageing
A focused review on carnosine's interaction with the major biological hallmarks of aging — oxidative damage, glycation, mitochondrial decline, and proteostasis collapse. The author argues that the molecule's breadth of action is exactly what an anti-aging candidate should look like.
Carnosine prevents necrotic and apoptotic death of rat thymocytes via mitochondrial pathway
Isolated rat thymocytes were exposed to apoptotic and necrotic stress with or without carnosine present in the culture medium. Carnosine reduced both forms of cell death, with mitochondrial membrane integrity emerging as the principal mediator of the protective effect.
Unveiling the hidden therapeutic potential of carnosine, a molecule with a multimodal mechanism of action: a position paper
A position paper consolidating the case that carnosine's clinical relevance has been systematically underestimated. The authors organize the mechanistic evidence into five interlocking modes of action and outline a roadmap for prioritizing translational trials.
Physiology and pathophysiology of carnosine
A reference review covering carnosine's distribution, synthesis, transport, and degradation, with a structured section on how disturbances in any of these steps map to disease states — muscular, ocular, renal, and neurological alike.
A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus
Longitudinal genetic study in type 1 diabetes patients showing that a polymorphism in the carnosinase gene predicts who progresses from diabetic nephropathy to end-stage renal disease and who dies sooner. Direct human evidence that endogenous carnosine handling shapes diabetic outcomes.
Effects of carnosine supplementation on glucose metabolism: pilot clinical trial
Pilot clinical trial in adults with disordered glucose handling, randomizing participants to carnosine versus placebo. The carnosine arm showed improved insulin sensitivity readouts, providing early human validation for the preclinical metabolic story.
Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E(-/-) mice
Diabetic apoE-knockout mice — a workhorse model for accelerated atherosclerosis — received carnosine over a chronic feeding window. Plasma triglycerides fell and the composition of vascular plaques shifted toward a more stable phenotype, linking carnosine to cardiometabolic risk modification.
Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats
Topical eye-drop formulations of carnosine, aminoguanidine, and aspirin were tested against placebo in diabetic rats prone to cataract formation. Carnosine drops delayed lens opacification, supporting a local anti-glycation mechanism in ocular tissue.
Carnosine supplementation protects rat brain tissue against ethanol-induced oxidative stress
Rats exposed to chronic ethanol — a reliable oxidative challenge to brain tissue — were protected by carnosine supplementation, with reduced lipid peroxidation and preserved antioxidant enzyme activity in cortex and hippocampus.
Effects of supplementation with carnosine and other histidine-containing dipeptides on chronic disease risk factors and outcomes: protocol for a systematic review of randomised controlled trials
Published protocol for a systematic review of randomized controlled trials testing carnosine and related dipeptides against chronic disease risk markers, with prespecified outcomes spanning glycemia, lipid handling, and inflammation. Important context for interpreting later pooled analyses.
Carnosine, small but mighty — prospect of use as functional ingredient for functional food formulation
A formulation-oriented review that examines carnosine's stability, bioavailability ceiling, and ingredient compatibility, then considers whether functional-food matrices can deliver clinically meaningful doses given the dipeptide's rapid hydrolysis in plasma.
Effect of beta-alanine supplementation on muscle carnosine concentrations and exercise performance
Human supplementation study quantifying how oral β-alanine raises intramuscular carnosine over weeks, and tying those biochemical gains to improved performance on high-intensity exercise tasks. A foundational reference for the β-alanine → carnosine → performance chain.
Beta-alanine supplementation augments muscle carnosine content and attenuates fatigue during repeated isokinetic contraction bouts in trained sprinters
Trained sprinters received β-alanine over a loading protocol, after which muscle biopsies confirmed elevated carnosine and isokinetic testing showed reduced fatigue across repeated maximal bouts — a clean cause-and-effect chain in an already trained population.
Effect of beta-alanine and carnosine supplementation on muscle contractility in mice
Mouse study comparing β-alanine, carnosine, and combined supplementation against the contractile performance of isolated muscle preparations. Both molecules improved force and fatigue resistance, with additive effects under combined dosing.
Carnosine: from exercise performance to health
A transition-oriented review that begins with carnosine's classical ergogenic story — pH buffering in working muscle — and walks outward into systemic health benefits driven by the same antioxidant and anti-glycation chemistry.
A systematic risk assessment and meta-analysis on the use of oral β-alanine supplementation
Meta-analytic risk assessment pooling β-alanine trials to evaluate adverse events alongside efficacy. The headline finding: at typical loading doses the safety profile is benign, with paresthesia the most consistent — and benign — observation.
Effect of carnosine and anserine on exercise performance and quality of life in older adults: a systematic review and meta-analysis
Systematic review and meta-analysis pooling trials in older adults receiving carnosine or anserine. Across studies, supplementation improved physical performance metrics and quality-of-life scores — strengthening the geroprotective case beyond athletic populations.
Carnosine inhibits glioblastoma growth independent from PI3K/Akt/mTOR signaling
Glioblastoma cell lines were exposed to carnosine and tracked for proliferation, with pathway analysis ruling out PI3K/Akt/mTOR as the responsible signaling axis. The growth inhibition is real but operates through alternative — and unidentified — mechanisms.
Carnosine retards reactive oxygen species-mediated hamster cheek pouch carcinogenesis
Classic carcinogenesis model in hamster cheek pouch tissue showing that carnosine slows tumor development driven by reactive oxygen species. Maps the antioxidant mechanism onto an oncologic endpoint rather than a metabolic one.
Carnosine inhibits migration and invasion of colorectal cancer cells by disrupting the STAT3 signaling pathway
Mechanistic in vitro study showing that carnosine suppresses migration and invasion in colorectal cancer cell lines by directly disrupting STAT3 signaling — a pathway central to metastasis. The phenotype-mechanism pairing is unusually clean for this literature.
The hepatoprotective effect of carnosine against ischemia/reperfusion liver injury in rats
Rat model of hepatic ischemia–reperfusion injury comparing carnosine-treated animals against controls. The treated group showed lower liver enzyme release and better preserved tissue architecture, extending the protective story to abdominal organs.
Distribution of carnosine-like peptides in the nervous system of developing and adult zebrafish (Danio rerio) and embryonic effects of chronic carnosine exposure
Comparative biology study mapping carnosine-like peptides through zebrafish development and tracking how chronic carnosine exposure influences embryogenesis. Useful primarily as a model-organism reference for evolutionary conservation of the pathway.
Carnosine protects against cisplatin-induced acute kidney injury in mice
Mice receiving the chemotherapeutic cisplatin — a reliable cause of acute kidney injury — were co-treated with carnosine. Kidney function markers were preserved and histological damage was attenuated, raising the possibility of carnosine as a renal adjunct in oncology.
Carnosine: its properties, functions and potential therapeutic applications
An early — and still influential — survey that laid out carnosine's physicochemical properties and floated therapeutic applications long before most of the modern evidence existed. Reads as the manifesto that shaped the next three decades of work.
Carnosine-induced neuroprotection involves mitochondrial preservation and H2O2 detoxification
Neuronal cell experiments isolating two distinct contributions to carnosine's protective effect: preservation of mitochondrial membrane potential and direct detoxification of hydrogen peroxide. Demonstrates that the neuroprotective phenotype rests on more than one mechanism.
Carnosine and homocarnosine interaction with membrane phospholipids
Biophysical study characterizing how carnosine and homocarnosine interact with model phospholipid membranes. Both peptides stabilize the bilayer against oxidative perturbation, hinting at a structural — not purely chemical — mode of cytoprotection.
Carnosine as an inhibitor of protein carbonylation in vitro
Controlled in vitro assay showing that carnosine inhibits protein carbonylation — one of the most damaging and irreversible forms of oxidative protein modification. Mechanism of choice for explaining tissue-level protein homeostasis benefits.
Carnosine: physiological properties and therapeutic potential
A turn-of-the-century review compiling carnosine's known physiological roles — pH buffering, metal chelation, oxidative defense — and arguing for therapeutic potential well outside the muscle-physiology niche it was best known for at the time.
Carnosine and anserine as modulators of neutrophil function
Targeted review on how carnosine and anserine influence neutrophil behavior — chemotaxis, oxidative burst, resolution of inflammation — positioning the dipeptide pair as immune modulators rather than pure antioxidants.
Carnosine metabolism in health and disease
A recent review centering on carnosine metabolism itself — synthesis, transport, degradation by carnosinases — and how perturbations of each step show up across disease. Reflects the field's pivot toward thinking of carnosine as a regulated pathway, not a free-floating nutrient.
Beta-alanine supplementation and exercise capacity: a large systematic review and meta-analysis
A landmark meta-analysis pooling more than forty controlled trials of β-alanine supplementation to quantify its effect on exercise capacity and performance. The pooled estimate is a small-to-moderate ergogenic benefit, most pronounced for continuous and intermittent efforts in the one-to-four-minute window where intramuscular acidosis is the dominant fatigue driver — the exact place carnosine's pH-buffering chemistry should matter most.
Oral β-alanine absorption kinetics and muscle carnosine synthesis in the human vastus lateralis
The foundational human pharmacokinetic study that mapped how oral β-alanine is absorbed, distributed, and ultimately incorporated into muscle carnosine over weeks of supplementation. The data established β-alanine — not carnosine itself — as the rate-limiting substrate for raising intramuscular carnosine, and set the dosing logic the field still uses today.
Diet, sex, and age as determinants of muscle carnosine concentration in healthy humans
Cross-sectional human study mapping how diet, biological sex, and chronological age shape baseline intramuscular carnosine. Plant-only eaters and women carry meaningfully lower muscle carnosine than meat-eating men, while concentrations decline progressively with age — a triple lens that helps explain who stands to gain most from supplementation.
Carnosine in cardiometabolic disease: physiology, evidence, and therapeutic potential
A focused review that gathers the human and animal evidence for carnosine in cardiometabolic disease — insulin resistance, dyslipidaemia, hypertension, and the cluster syndrome that links them. The authors argue that the molecule's dual antioxidant and carbonyl-quenching chemistry is precisely the intervention this disease cluster needs.
Carnosine attenuates the development of type 2 diabetes and diabetic nephropathy in BTBR ob/ob mice
Genetically obese BTBR ob/ob mice — a model that develops type 2 diabetes and diabetic nephropathy on a predictable timeline — were treated with carnosine added to drinking water. The intervention slowed onset of hyperglycemia and protected kidney architecture, providing strong preclinical support for carnosine as a metabolic and renal disease modifier rather than a symptom manager.
Carnosine reduces dyslipidaemia and improves renal function in Zucker obese rats via carbonyl scavenging
In Zucker obese rats — a benchmark model for metabolic syndrome — chronic carnosine treatment lowered circulating lipids and protected renal function. The authors trace the effect back to a single mechanism: scavenging reactive carbonyl species before they can crosslink lipoproteins and damage glomerular tissue.
The anti-ageing actions of carnosine: mechanisms, paradoxes, and open questions
An influential opinion review that confronts the paradox at the heart of the field: carnosine produces broad anti-ageing effects across very different model systems, but no single mechanism accounts for all of them. The author argues this multiplicity is the feature, not the bug — and outlines where future work needs to focus.
Chronic dietary carnosine improves cognition and reduces anxiety in a transgenic Alzheimer's mouse model
Long-running feeding study in a transgenic Alzheimer's mouse model comparing chronic dietary carnosine against control diet. Carnosine-fed mice performed better on memory tasks, showed less anxiety-like behavior, and carried lower brain inflammation markers — a behavioral and neurochemical picture that lines up with the antioxidant and anti-glycation hypothesis.
Antioxidant and neuroprotective effects of carnosine: therapeutic implications in neurodegenerative disease
A modern mechanistic review focused on carnosine's antioxidant chemistry and how that chemistry maps onto neurodegenerative disease — Alzheimer's, Parkinson's, ALS, and Huntington's. The authors organize the evidence around the shared upstream driver of oxidative stress, then weigh translational readiness disease by disease.
N-acetylcarnosine eye drops for age-related cataract: mechanism, clinical evidence, and outlook
The defining review of the N-acetylcarnosine eye-drop literature, written by the program's lead investigator. It covers why a topical prodrug is required to reach the lens, the trial evidence behind glare and visual-acuity improvements, and the unresolved questions clinicians still ask about long-term use.
Topical carnosine against photoaging: anti-glycation defense for the dermal collagen matrix
A synthesis review of how topical carnosine protects the dermal extracellular matrix against the two main drivers of skin aging: ultraviolet-induced oxidative stress and chronic glycation of collagen and elastin. The piece is practical — it weighs formulation, penetration, and pairing with established cosmeceutical actives.
Carnosine and inflammaging: dampening chronic low-grade inflammation in older adults
A focused review on inflammaging — the chronic, low-grade inflammation that accumulates with age and underwrites most non-communicable disease. The authors argue carnosine sits at the right intersection of anti-glycation, anti-oxidant, and immune-modulating chemistry to be a credible nutritional lever on this process, and survey the supporting human evidence.
L-carnosine supplementation in women with polycystic ovary syndrome: metabolic and oxidative outcomes
Clinical-trial literature evaluating oral L-carnosine in women with polycystic ovary syndrome — a metabolic-endocrine condition tightly linked to insulin resistance and oxidative stress. Reported endpoints span insulin sensitivity, androgen profile, and circulating oxidative-stress markers, all of which move modestly in the expected direction with active supplementation.
Every claim links back to a primary source.
We index public literature from the National Library of Medicine and write our own plain-language summaries. Every study card carries a direct link to the original PubMed or PMC record — no paywall workarounds, no rewritten findings, just a guided path to the evidence.
Check out our insights section for in-depth analysis of the studies on topical carnosine and its delivery methods, or comparisons to the existing delivery methods of the Longevity Molecule Plus, as well as additional information on what carnosine can do for you.
Visit Insights